Stay updated with breaking news from Roviant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bob Elliott is co-founder, CEO and chief investment officer at Unlimited, a fintech company specializing in building products that replicate the index returns of alternative investments.
The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.
Vivek Ramaswamy — author of ‘Woke, INC.’ and founder of Roviant Sciences — currently is working hard to TAKE BACK control from the three largest asset managers in the world…including BlackRock, which manages over 10 TRILLION dollars of everyday Americans' finances (that's more than half the U.S. GDP...
Share: A drug discovery company with ownership stakes in several public and private biopharmaceutical companies is going public with a SPAC deal announced Monday morning. The SPAC Deal: Roviant Sciences announced a SPAC deal with Montes Archimedes Acquisition Corp (NASDAQ: MAAC). The deal values the company at an enterprise value of $5 billion. A $200 million PIPE is backed by companies including Softbank Group Corp., Fidelity Management & Research Co., Sumitomo Dainippon Pharma and Palantir Technologies Inc (NYSE: PLTR). Shares of the new company will trade as ROIV on the Nasdaq with an a...